BBH Holdings — VanEck Biotech ETF
All 25 reported holdings of VanEck Biotech ETF (BBH) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Gilead Sciences Inc | 14.63% | $54.37M |
| Amgen Inc | 14.54% | $54.04M |
| Vertex Pharmaceuticals Inc | 8.06% | $29.94M |
| Regeneron Pharmaceuticals Inc | 7.51% | $27.92M |
| Argenx SE | 5.28% | $19.61M |
| Insmed Inc | 4.59% | $17.05M |
| IQVIA Holdings Inc | 4.30% | $15.97M |
| Alnylam Pharmaceuticals Inc | 4.11% | $15.26M |
| Natera Inc | 3.98% | $14.79M |
| United Therapeutics Corp | 3.81% | $14.15M |
| Biogen Inc | 3.72% | $13.83M |
| BeOne Medicines Ltd | 3.25% | $12.06M |
| Moderna Inc | 3.10% | $11.53M |
| Revolution Medicines Inc | 2.86% | $10.64M |
| Illumina Inc | 2.49% | $9.26M |
| Incyte Corp | 2.25% | $8.35M |
| BioNTech SE | 2.15% | $8.01M |
| Neurocrine Biosciences Inc | 1.94% | $7.20M |
| BioMarin Pharmaceutical Inc | 1.39% | $5.17M |
| Bio-Techne Corp | 1.35% | $5.01M |
| Charles River Laboratories International Inc | 1.28% | $4.75M |
| Icon PLC | 1.27% | $4.73M |
| Qiagen NV | 1.15% | $4.26M |
| Tempus AI Inc | 0.93% | $3.44M |
| State Street Global Advisors | 0.23% | $853.19K |